This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Opko Health Inc (OPK)

NYSE: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -31.43M -174.64M -117.35M -29.54M
Operating Gains/Losses -2.69M 1.09M -9.68M 2.06M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -29.39M -3.92M 754.00K 763.00K
(Increase) Decrease in Inventories -5.88M -1.75M 1.89M -5.81M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -18.12M -3.85M 1.83M 1.25M
(Decrease) Increase In Other Current Liabilities 9.50M 4.93M 779.00K 2.36M
(Increase) Decrease In Other Working Capital 228.34M -2.43M -2.93M -275.00K
Other Non-Cash Items 98.15M 69.06M 50.65M 6.44M
Net Cash From Continuing Operations 164.02M -90.38M -58.19M -25.42M
Net Cash From Discontinued Operations 0.00 0.00 0.00 7.00K
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 164.02M -90.38M -58.19M -25.41M
Sale of Property, Plant & Equipment 0.00 0.00 636.00K 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 50.03M 25.00M
Purchases of Property, Plant & Equipment -15.85M -4.73M -3.96M -1.47M
Acquisitions -79.00M -1.68M 20.53M -19.09M
Purchases of Short-Term Investments 0.00 0.00 -50.03M -25.81M
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -99.22M -5.67M 30.32M -24.77M
Issuance of Debt 261.34M 26.44M 204.76M 36.51M
Cash Used for Financing Activities
Issuance of Capital Stock 25.92M 12.93M 23.43M 2.28M
Repayment of Long-Term Debt -254.35M -28.37M -39.00M -32.75M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 -3.02M 0.00
Other Financing Charges, Net 100.00K -3.74M 0.00 0.00
Net Cash From Financing Activities 33.01M 7.26M 186.17M 6.03M
Effect of Exchange Rate Changes -1.12M -100.00K 138.00K -2.00K
Net Change in Cash & Cash Equivalents 96.69M -88.89M 158.44M -44.16M
OPK News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for OPK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

OPK Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs